Therapeutic preparations are provided for treatment of a T-cell mediated disease or condition comprising an antigen and a carrier, wherein said antigen is an antigen recognized by inflammatory T cells associated with the pathogenesis of said T-cell mediated disease or condition, and wherein said carrier is an anti-inflammatory immunomodulator selected from: (a) a saturated or cis-unsaturated C10-C20 fatty alcohol or an ester thereof with a C1-C6 alkanoic acid; and (b) a saturated or cis-unsaturated C10-C20 fatty acid ester selected from a C1-C6 alkyl ester, a monoester with a C2-C6 polyol having a least two hydroxy groups, and a diester with glycerol.
本发明提供了用于治疗T细胞介导的疾病或病症的治疗制剂,该制剂包含抗原和载体,其中所述抗原是与所述T细胞介导的疾病或病症的发病机制相关的炎性T细胞识别的抗原,所述载体是选自以下物质的抗炎免疫调节剂:(a) 饱和或顺式不饱和 C10-C20
脂肪醇或其与 C1-C6 烷酸的酯;和 (b) 饱和或顺式不饱和 C10-C20
脂肪酸酯,选自 C1-C6 烷基酯、与具有至少两个羟基的 C2-C6 多元醇的单酯和与
甘油的二酯。